Juvenile Diabetes Research Foundation salutes passage of Senate stem cell bill

April 11, 2007, Washington, DC -- The Juvenile Diabetes Research Foundation, the worlds largest charitable funder of type 1 diabetes research, praised todays historic vote in the U.S. Senate to expand federal funding for embryonic stem cell research with the passage of S. 5, the Stem Cell Research Enhancement Act of 2007.

"The Senate passage of this bill marks another important step in the road to find a cure for type 1 diabetes and related complications," said Larry Soler, Vice President of Government Relations for JDRF. "We need to accelerate the development of a cure for diabetes, and this legislation will ensure that scientists will be able to pursue the potential benefits of stem cell research. I hope that the President listens to the voices of the tens of millions of Americans with diabetes and other diseases who are calling for action, and signs this bill into law."

"Id like to thank the lead authors of the bill: Senators Reid, Harkin, Specter, Kennedy, Hatch, Feinstein, and Smith," added Mr. Soler. "Id also like to thank the original authors of the House bill, Representatives Diana DeGette and Michael Castle, for their tireless work in promoting stem cell research. Finally, and equally importantly, Id like to salute the tireless efforts of our thousands of grassroots volunteers from around the country who met with their elected officials and stayed in close contact with them to ensure the positive conclusion of todays historic vote. Their enthusiasm and commitment to work with legislators to speed the discovery of cures for themselves and their loved ones is both admirable and heartening as we explore a wide range of scientific opportunities in our search for a cure."


Contact: Peter Cleary
Juvenile Diabetes Research Foundation International

Page: 1

Related biology news :

1. Diabetes gene may be linked to polycystic ovary syndrome
2. Joslin Diabetes Center study examines insulin pump therapy in adolescents
3. Diabetes gene carries similar risk to obesity
4. Joslin Diabetes Center in Boston establishes first affiliate in Canada
5. Walgreens and Joslin Diabetes Center form broad alliance to improve diabetes outcomes
6. Diabetes slows nerve recovery after heart transplant
7. Diabetes research takes wing thanks to long-lived fruit fly
8. Diabetes hits 275 Australians each day as pandemic spreads
9. Joslin Diabetes Center partners with St. John Healths Providence hospital in Michigan
10. Diabetes and cancer: Alpha connection
11. Diabetes research yielding breakthrough success

Post Your Comments:

(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical ... discover a COVID cure or vaccine, the global economic downturn will only increase price ... not going away and capturing full value from every product launch is critical. However, ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced ... will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional ... Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , ... biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology ... Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... access to competitively procured purchasing contracts to its membership, recently named BioFit ... TIPS members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks ...
(Date:6/28/2020)... NIGUEL, Calif. (PRWEB) , ... June 25, 2020 , ... ... announced the launch of Safe Space™ for businesses of all types to ensure cleanliness, ... 3D LiDAR. , A Safe Space™ enabled business will provide a health ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... photodynamic therapy for treating cancer, today announced the company has entered a license ... The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. , developers ... announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The ... of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 ...
Breaking Biology Technology:
Cached News: